These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33563731)

  • 1. Saudi Arabia Guidelines for diabetic macular edema: A consensus of the Saudi Retina Group.
    AlQahtani AS; Hazzazi MA; Waheeb SA; Semidey VA; Semidey VA; Elgendy HK; Alkhars WI; Abouammoh MA; Al-Dhibi H
    Saudi Med J; 2021 Feb; 42(2):131-145. PubMed ID: 33563731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
    Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
    Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of diabetic macular edema: experts' consensus in Taiwan.
    Chen JT; Chen LJ; Chen SN; Chen WL; Cheng CK; Hsu SM; Sheu SJ; Wu WC; Yang CH; Yang CM; Yeung L; Hwang DK; Chen SJ
    Jpn J Ophthalmol; 2020 May; 64(3):235-242. PubMed ID: 32342244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal steroids for macular edema in diabetes.
    Rittiphairoj T; Mir TA; Li T; Virgili G
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for the management of diabetic macular oedema with intravitreal dexamethasone implant: A national Delphi consensus study.
    Kodjikian L; Baillif S; Couturier A; Creuzot-Garcher C; Delyfer MN; Matonti F; Weber M
    Eur J Ophthalmol; 2022 Sep; 32(5):2845-2856. PubMed ID: 34779302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 Eyes.
    Ciulla TA; Hussain RM; Taraborelli D; Pollack JS; Williams DF
    Ophthalmol Retina; 2022 Sep; 6(9):796-806. PubMed ID: 35381391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach.
    Giovannini A; Parravano M; Ricci F; Bandello F
    Eur J Ophthalmol; 2019 Jan; 29(1):82-91. PubMed ID: 29882421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor and diabetic macular edema.
    Lally DR; Shah CP; Heier JS
    Surv Ophthalmol; 2016; 61(6):759-768. PubMed ID: 27045225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines.
    Das T; Aurora A; Chhablani J; Giridhar A; Kumar A; Raman R; Nagpal M; Narayanan R; Natarajan S; Ramasamay K; Tyagi M; Verma L
    Indian J Ophthalmol; 2016 Jan; 64(1):14-25. PubMed ID: 26953019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach.
    García Layana A; Adán A; Ascaso FJ; Cabrera F; Donate J; Escobar Barranco JJ; Peralta G; Reyes García R; Rodríguez Maqueda M; Ruiz-Moreno JM; Vinagre I;
    Eur J Ophthalmol; 2020 Sep; 30(5):1042-1052. PubMed ID: 31291782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of metformin treatment with enhanced effect of anti-VEGF agents in diabetic macular edema patients.
    Shao Y; Wang M; Zhu Y; Li X; Liu J
    Acta Diabetol; 2022 Apr; 59(4):553-559. PubMed ID: 35034186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.
    Do DV; Schmidt-Erfurth U; Gonzalez VH; Gordon CM; Tolentino M; Berliner AJ; Vitti R; Rückert R; Sandbrink R; Stein D; Yang K; Beckmann K; Heier JS
    Ophthalmology; 2011 Sep; 118(9):1819-26. PubMed ID: 21546089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the effect of vitreomacular interface abnormalities on anti-vascular endothelial growth factor treatment outcomes in diabetic macular edema by optical coherence tomography: A systematic review and meta-analysis.
    Gong Y; Wang M; Li Q; Shao Y; Li X
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103555. PubMed ID: 37088331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial.
    Mi X; Gu X; Yu X
    Trials; 2022 Sep; 23(1):736. PubMed ID: 36056443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical Decision Making for Treatment of Diabetic Macular Oedema with DEX Implant: a Consensus Paper].
    Augustin AJ; Feltgen N; Haritoglou C; Hoerauf H; Maier MM; Mardin CY; Schargus M
    Klin Monbl Augenheilkd; 2021 Jan; 238(1):73-84. PubMed ID: 31770786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic Macular Edema: Traditional and Novel Treatment.
    Tomić M; Vrabec R; Poljičanin T; Ljubić S; Duvnjak L
    Acta Clin Croat; 2017 Mar; 56(1):124-132. PubMed ID: 29120156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.